Novavax (NVAX)
(Delayed Data from NSDQ)
$10.18 USD
-0.17 (-1.64%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $10.21 +0.03 (0.29%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-0.87 | -12.97% |
Earnings Summary
For their last quarter, Novavax (NVAX) reported earnings of $0.99 per share, missing the Zacks Consensus Estimate of $1.82 per share. This reflects a negative earnings surprise of 45.60%. Look out for NVAX's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$0.87 per share, reflecting a year-over-year increase of 30.95%.
Earnings History
Price & Consensus
Zacks News for NVAX
Biotech Stock Roundup: VNDA, JAZZ Up on Updates, NVAX Suffers Setback & More
NVAX: What are Zacks experts saying now?
Zacks Private Portfolio Services